Among the many metrics that exist to quantify GV, CV is the most appropriate measure to identify short-term glycemic variability and levels for patients with diabetes should be kept below 36%4, although some studies recommend lower targets (< 33%) for patients treated with insulin to reduce the risk of hypoglycemia30. This evidence concerns the gene INS and diabetes mellitus.